The present report is concerned with a stereoselective, reliable route to trans-1, 2- disubstituted cyclopropanes and in particular to (S, S)-1-tosyloxymethyl-2-fluoromethyl- cyclopropane (1) and (R, R)-1-tosyloxymethyl-2-fluoromethyl-cyclopropane (ent-1) as conformationally restricted, terminally fluorinated C4-building blocks for medicinal chemistry. The enzymatic kinetic resolution based synthesis of 1 and ent-1 utilises inexpensive, ...